[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![tenet_research Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::706191666219196420.png) TENET RESEARCH [@tenet_research](/creator/twitter/tenet_research) on x 452.5K followers
Created: 2025-06-15 14:09:37 UTC

$GMAB - Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1934251955754307965/c:line.svg)

**Related Topics**
[$gmabco](/topic/$gmabco)
[$gmab](/topic/$gmab)

[Post Link](https://x.com/tenet_research/status/1934251955754307965)